A detailed history of Glen Eagle Advisors, LLC transactions in Sanofi stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 79 shares of SNY stock, worth $4,086. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79
Previous 1,365 94.21%
Holding current value
$4,086
Previous $54.7 Million 92.99%
% of portfolio
0.0%
Previous 0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$45.39 - $50.36 $58,371 - $64,762
-1,286 Reduced 94.21%
79 $3.83 Million
Q1 2023

Aug 13, 2024

SELL
$45.86 - $54.45 $1,605 - $1,905
-35 Closed
0 $0
Q4 2022

Aug 13, 2024

BUY
$38.86 - $48.55 $1,360 - $1,699
35 New
35 $1.7 Million
Q1 2022

Aug 13, 2024

SELL
$48.48 - $53.65 $4,848 - $5,365
-100 Closed
0 $0
Q4 2021

Aug 13, 2024

SELL
$47.07 - $52.35 $38,362 - $42,665
-815 Reduced 89.07%
100 $5.01 Million
Q2 2021

Aug 13, 2024

SELL
$49.36 - $54.25 $34,552 - $37,975
-700 Reduced 43.34%
915 $48.2 Million
Q4 2020

Aug 13, 2024

BUY
$45.3 - $51.62 $73,159 - $83,366
1,615 New
1,615 $78.5 Million
Q2 2020

Aug 13, 2024

BUY
$42.91 - $52.5 $35,186 - $43,050
820 Added 50.0%
2,460 $126 Million
Q1 2019

Aug 13, 2024

BUY
$40.83 - $45.43 $66,961 - $74,505
1,640 New
1,640 $72.6 Million
Q2 2018

Aug 13, 2024

SELL
$37.63 - $41.22 $1.07 Million - $1.17 Million
-28,333 Reduced 95.4%
1,365 $54.6 Million
Q1 2018

Aug 14, 2024

BUY
$38.98 - $45.76 $53,207 - $62,462
1,365 New
1,365 $54.7 Million
Q1 2018

Aug 13, 2024

BUY
$38.98 - $45.76 $1.12 Million - $1.32 Million
28,783 Added 3145.68%
29,698 $54.7 Million
Q3 2017

Aug 13, 2024

BUY
$47.04 - $50.34 $43,041 - $46,061
915 New
915 $45.6 Million
Q2 2017

Aug 12, 2024

BUY
N/A
25 Added 3.57%
725 $34.7 Million
Q4 2016

Aug 12, 2024

BUY
N/A
700
700 $28.3 Million

Others Institutions Holding SNY

About Sanofi


  • Ticker SNY
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,508,100,096
  • Market Cap $130B
  • Description
  • Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...
More about SNY
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.